I feel very sad for you that during this Christmas month you have nothing better to do then that. Btw, GILD was a 50 cent stock 20 years ago. Do some research.
In 1990, Gilead entered into a collaborative research agreement with Glaxo for the research and development of genetic code blockers, also known as antisense. This collaboration was terminated in 1998, and Gilead's antisense intellectual property portfolio was sold to Ionis Pharmaceuticals. Gilead debuted on the NASDAQ in January 1992. Its initial public offering raised $86.25 million in proceeds. In 19o9 its sales were 40 mill$
Market Data 
Markets 
AI
